Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Gut Microbiome Manipulation in 5xFAD Mice on Alzheimer’s Disease-Like Pathology
Malena dos Santos Guilherme, Vu Thu Thuy Nguyen, Christoph Reinhardt, et al.
Microorganisms (2021) Vol. 9, Iss. 4, pp. 815-815
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Sidhanth Chandra, Sangram S. Sisodia, Robert Vassar
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 152
Gut microbiome-targeted therapies for Alzheimer’s disease
Tao Zhang, Guangqi Gao, Lai‐Yu Kwok, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 42
The gut microbiome and Alzheimer’s disease: Complex and bidirectional interactions
Rawan Tarawneh, Elena Penhos
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104814-104814
Open Access | Times Cited: 50
Gut Microbiota and Alzheimer’s Disease: How to Study and Apply Their Relationship
Ngoc Minh Nguyen, Jungsook Cho, Choong-Ho Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4047-4047
Open Access | Times Cited: 24
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 14
Bazi Bushen capsule improves the deterioration of the intestinal barrier function by inhibiting NLRP3 inflammasome-mediated pyroptosis through microbiota-gut-brain axis
Shi-Xiong Zhang, Mengnan Li, Liping Chang, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 8
Targeting gut microbiota to alleviate neuroinflammation in Alzheimer’s disease
Vu Thu Thuy Nguyen, Kristina Endres
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114418-114418
Closed Access | Times Cited: 35
Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer’s Disease
Sage J. B. Dunham, Katelyn McNair, Eric D. Adams, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 35
Modulation of the Gut Microbiota and Glycometabolism by a Probiotic to Alleviate Amyloid Accumulation and Cognitive Impairments in AD Rats
Yuanwang Wang, Dehua Wang, Houjiao Lv, et al.
Molecular Nutrition & Food Research (2022) Vol. 66, Iss. 19
Closed Access | Times Cited: 31
The gut microbiota is an emerging target for improving brain health during ageing
Marcus Boehme, Katherine E. Guzzetta, Caroline Wasén, et al.
Gut Microbiome (2022) Vol. 4
Open Access | Times Cited: 28
Role of gut microbiota in the modulation of the health effects of advanced glycation end‑products (Review)
Michael Aschner, Anatoly V. Skalny, В. А. Гриценко, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 5
Open Access | Times Cited: 16
A Systematic Review on the Effects of Different Types of Probiotics in Animal Alzheimer's Disease Studies
Tanja J. de Rijke, M. H. Edwina Doting, Saskia van Hemert, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 27
Implications of Microorganisms in Alzheimer’s Disease
Pardeep Yadav, Yeon‐Hee Lee, Hrithika Panday, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 10, pp. 4584-4615
Open Access | Times Cited: 19
Correlation between Alzheimer’s Disease and Gastrointestinal Tract Disorders
Julia Kuźniar, Patrycja Kozubek, Magdalena Czaja, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2366-2366
Open Access | Times Cited: 4
A Review of the Consequences of Gut Microbiota in Neurodegenerative Disorders and Aging
Amanda A. Menezes, Zahoor A. Shah
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1224-1224
Open Access | Times Cited: 4
The same but different: impact of animal facility sanitary status on a transgenic mouse model of Alzheimer’s disease
Caroline Ismeurt, Patrizia Giannoni, Florence Servant, et al.
mBio (2025)
Open Access
microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD)
Aileen I. Pogue, Walter J. Lukiw
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9198-9198
Open Access | Times Cited: 25
Age-dependent effects of gut microbiota metabolites on brain resident macrophages
Dilara Hasavci, Thomas Blank
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 17
Novel Insights into the Role of Probiotics in Respiratory Infections, Allergies, Cancer, and Neurological Abnormalities
Igori Balta, Eugenia Butucel, Valentyn Mohylyuk, et al.
Diseases (2021) Vol. 9, Iss. 3, pp. 60-60
Open Access | Times Cited: 21
Depletion of gut microbiota resistance in 5×FAD mice enhances the therapeutic effect of mesenchymal stem cell-derived exosomes
Xuejia Hou, Hongyu Jiang, Te Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114455-114455
Open Access | Times Cited: 8
Impact of the Age of Cecal Material Transfer Donors on Alzheimer’s Disease Pathology in 5xFAD Mice
Francesco Valeri, Malena dos Santos Guilherme, Fu‐Qian He, et al.
Microorganisms (2021) Vol. 9, Iss. 12, pp. 2548-2548
Open Access | Times Cited: 20
The role of the gut microbiome in the regulation of astrocytes in Alzheimer's disease
Sidhanth Chandra, Robert Vassar
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00425-e00425
Closed Access | Times Cited: 2
Gut Microbiota and Alzheimer's Disease: Exploring Natural Product Intervention and the Gut–Brain Axis for Therapeutic Strategies
Jajati K. Pasupalak, Prabha Rajput, Girdhari Lal Gupta
European Journal of Pharmacology (2024), pp. 177022-177022
Closed Access | Times Cited: 2
Exogenous Short Chain Fatty Acid Effects in APP/PS1 Mice
Diana J. Zajac, Benjamin C. Shaw, David J. Braun, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 9
Resilience and the Gut Microbiome: Insights from Chronically Socially Stressed Wild-Type Mice
Malena dos Santos Guilherme, Francesco Valeri, Jennifer Winter, et al.
Microorganisms (2022) Vol. 10, Iss. 6, pp. 1077-1077
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top